September 14, 2022 - CPRT Open Seminar
Kevin Outterson , J.D., LL.M, Executive Director, CARB-X
"Repairing the broken business model for antimicrobial R&D"
Professor Outterson teaches health care law at Boston University, where he co-directs the Health Law Program. He serves as the founding Executive Director and Principal Investigator for CARB-X, an >$800M international public-private partnership to accelerate global antibacterial innovation. Key partners in CARB-X include the US Government (BARDA & NIAID), the Wellcome Trust, the German Federal Ministry of Education and Research (BMBF), the UK Government (GAMRIF), and the Bill & Melinda Gates Foundation. Professor Outterson’s research work focuses on the law and economics of antimicrobial resistance, particularly push and pull incentives for antimicrobials.
Learn more about Kevin Outterson on the CARB-X website